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Abstract
Introduction: Influenza viruses specifically, A and B mainly contribute to seasonal outbreaks that occur globally.
However, due to limited diagnostics for influenza there is little data regarding clinical outcomes of patients with
H1N1 pneumonia in our region. Our objective was to determine the clinical characteristics and outcomes of
patients hospitalized with H1N1 pneumonia at a tertiary care facility in Karachi, Pakistan.
Methods: A retrospective study of adult patients admitted with influenza pneumonia from November 2017 to
February 2018 at a tertiary care hospital in Karachi, Pakistan. Patient characteristics were compared between
influenza A H1N1 and other types of influenza using multivariable logistic regression analysis and subgroup analysis
for factors associated with mortality in H1N1 Pneumonia was performed.
Results: Out of 497 adult patients with community acquired pneumonia (CAP), 172 fulfilled the criteria for Influenza
like illness (ILI). 88 patients had PCR confirmed Influenza pneumonia of whom n = 57 (65%) had Influenza A H1N1.
The mean age of patients 53.5 years (SD: 17.3) and 60% were male. The overall mortality from Influenza in this study
was 15.9% (n = 14); out of these 11 (78.5%) had Influenza A H1N1. Multivariable analysis showed that the increase in
length of hospital admission was significantly associated with H1N1 Influenza A infection (OR: 1.47 CI: 1.2–1.8).
Factors associated with mortality showed that presence of ARDS, Septic shock and multi-organ failure was highly
significantly associated with death (p-value < 0.001) along with deranged liver function tests (p-value 0.01) and
presence of nosocomial infection (p-value 0.027).
Conclusion: Influenza A H1N1 is associated with greater length of stay compared with infection due to other types
of Influenza and mortality in H1N1 Pneumonia was found to be associated with presence of nosocomial infection
among several other factors which may have implications given higher rates in a low-middle income country.
Keywords: Influenza, H1N1, Mortality
Background
Viral respiratory infections account for nearly 50% of
acute respiratory illness. Influenza viruses A and B cause
seasonal outbreaks with significant morbidity and mor-
tality. The first influenza A (swine flu) virus of the
H1N1 subtype was isolated from in humans in 1974 [1].
In 2009, the World Health Organization (WHO) an-
nounced a swine-oriented influenza virus pandemic,
H1N1 2009 pandemic [2]. During this outbreak in 2009/
2010, around 18,500 deaths were reported associated
with confirmed H1N1 influenza virus with a mortality
rate of 0.12 deaths per 100,000 populations [3]. Accord-
ing to United States Centers for Disease Control and
Prevention (CDC), there were 12,470 fatal cases based
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
* Correspondence: hussain.mujahid@aku.edu
1Department of Medicine, Section of Pulmonary and Critical Care Medicine,
Aga Khan University, Karachi, Pakistan
Full list of author information is available at the end of the article
PneumoniaHussain et al. Pneumonia            (2020) 12:5 https://doi.org/10.1186/s41479-020-00070-7
on data using mathematical models [4]. A majority of
patients with Influenza A H1N1 subtype usually present
with symptoms of upper and lower respiratory tract in-
fections such as, sudden onset of fever, cough, sore
throat, headache, myalgia, and generalized weakness.
The symptoms may be self-limiting in most but it can
progress to severe pneumonia, acute respiratory distress
syndrome (ARDS) and mortality [5, 6]. Studies have
shown that up to 66% hospitalized patients had chest
radiographic abnormalities compatible with pneumonia
[3]. There are no unique clinical features that distinguish
Influenza A subtype H1N1 infection from other forms of
viral respiratory infections. Although a number of pa-
tients had predisposing immune-compromising condi-
tions, healthy persons are also at risk for illness and
death from H1N1 Influenza pneumonia [2]. In a study
from Turkey; 30.6% patients presented with interstitial
infiltrates on chest radiograph and 36% with consolida-
tion [7]. Studies have shown increased severity of disease
in pregnant women, transplant recipients and patients
with malignancies [8, 9]. There have been conflicting
data from different parts of the world with some regions
reporting better survival in ventilated patients [10] and
some regions with poor outcomes in patients requiring
intensive care [11].
Influenza A H1N1 has been reported globally but
there is limited data available from Pakistan. In 2009, a
single center case series reported 36 confirmed H1N1
cases with 16.7% mortality from in Pakistan [12]. Most
of these cases were previously healthy individuals who
developed an influenza-like illness that progressed to
pneumonia within 5 to 7 days (5).
Despite yearly outbreaks each winter; data available
from Pakistan on clinical characteristics and outcomes
of H1N1 pneumonia patients is scarce [12, 13] and none
is available from recent outbreaks. The aim of the study
was to determine the clinical characteristics, course of
disease and outcomes of these patients when hospital-
ized with H1N1 pneumonia in tertiary care hospital.
Methods
Ethical approval
This study received approval from the Ethical Review
Committee of the hospital (5277-Med-ERC-18). The
data was collected from hospital records and the re-
quirement for informed consent was waived by the hos-
pital ethical review committee as data was anonymized
and no personal identifiers were collected.
Study population and design
We conducted a retrospective descriptive study of adult
patients admitted with a diagnosis of Influenza pneumo-
nia from November 2017 to February 2018 at a 700 bed-
ded tertiary care hospital in Karachi, Pakistan. All
patients admitted with the diagnosis of community ac-
quired pneumonia during the study period were identi-
fied from the hospital information management system.
Influenza-like illness (ILI) was defined as “An acute re-
spiratory illness with a measured temperature of ≥38 °C
and cough, with onset within the past 10 days” [14]. A
confirmed case of influenza pneumonia was defined as
an individual with an ILI with laboratory-confirmed in-
fluenza by Influenza virus PCR assay in respiratory
specimen.
Demographic and clinical characteristics of confirmed
influenza patients including, underlying medical and re-
spiratory co-morbidities and laboratory and radiological
investigations, treatment and complications during
hospitalization were collected on a structured performa
from hospital medical records.
Diagnosis of influenza
Nasopharyngeal swabs were processed for detection of
Influenza virus by real-time reverse transcriptase poly-
merase chain reaction (RT-PCR) using the Influenza
virus PCR assay (Altona Diagnostics, GmbH).
Radiological diagnosis of pneumonia was made by
evaluation of infiltrates observed on chest X ray and/or
CT chest scans. A multidisciplinary team of doctors in-
cluding infectious diseases consultants, pulmonologists
and intensivits were involved in identification of cases
and their management.
Data analysis
STATA ver 12.1was used for data analysis. Descriptive
analysis was performed for demographic features with
mean and standard deviation reported for quantitative
variables such as age and lengths of hospital stay and
frequencies (percentage) for qualitative variables such as
gender, co-morbid conditions, mortality and complica-
tions etc. χ2 test of independence or Fischer Exact test
was performed for comparison of factors between those
with H1N1 Influenza compared to those with Influenza
other than H1N1 subtype. Multivariable logistic regres-
sion analysis was performed on variables found to be sig-
nificant on univariate analysis to identify factors
associated with Influenza A H1N1 infection. All p value
≤0.05 was taken as significant. Subgroup analysis was
also done using χ2 test of independence or Fischer Exact
test for comparison between those who died compared
to those who recovered from H1N1 Influenza.
Results
Total of 497 patients of age 18 years and above were ad-
mitted during this period with community acquired
pneumonia (CAP) out of which 172 fulfilled the criteria
for Influenza like illness (ILI). Out of 172 patients admit-
ted with ILI, 88 (51%) patients fulfilled the criteria of
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confirmed Influenza pneumonia. Majority of the patients
had Influenza A H1N1 (n = 57) 65% while, (n = 6) 7% pa-
tients had non H1N1 Influenza A and (n = 25) 28% pa-
tients had Influenza B.
The mean age of patients with H1N1 Influenza was
53.5 years (SD: 17.3). Thirty-four patients (59.6%) were
female and six of them were pregnant. Hypertension was
the commonest co-morbid condition as found in 44% of
H1N1 cases. Sixty-three percent of the Influenza A
H1N1 patients were non-smokers. Only three (5.2%) pa-
tients had received quadrivalent inactivated influenza
vaccination.
Risk factors associated with influenza were evaluated
in patients with H1N1 influenza. None of the cases had
a recent history of travel outside of the country or, had
occupational exposure to livestock. Only one was a
health care provider. The median duration of illness
prior to presentation of Influenza was 5 days (IQR: 2)
(Table 1). Amongst Influenza A H1N1 patients, 96% pa-
tient had interstitial infiltrates on chest radiography and
the most frequently associated lung condition was
Chronic Obstructive Pulmonary disease (COPD) (n = 8).
Of patients with Influenza A H1N1 subtype, microbio-
logical cultures of respiratory secretions taken on admis-
sion were tested in 23 cases and were found to be
positive in 6 (26%) patients. Three patients had a poly-
microbial growth of Staphylococcus aureus and Aspergil-
lus species (two had A. flavus and one had A. fumigatus)
and three patients had isolated growth of Aspergillus fla-
vus. All patients with H1N1 influenza received Oseltami-
vir as well as antibiotics empirically.
The clinical outcomes of patients with Influenza A
H1N1 infection are summarized in Table 2. The mean
length of stay was 8 days (SD: 6). The overall mortality
from Influenza virus infection during this period was
15.9% (14/88). Eleven (78.5%) of 14 patients who died
were positive for Influenza A H1N1 subtype. Further,
the mortality in Influenza A subtype H1N1 pneumonia
was 19% (11/57).
The laboratory parameters including mean white
blood cell count, creatinine and blood glucose levels
were similar for both patients with H1N1 and influenza
other than H1N1 with the exception of transaminase
levels (SGPT and SGOT) which had a higher trend in
patients infected with Influenza A subtype H1N1 pneu-
monia (Supplementary Table 1).
Amongst patients with H1N1, nineteen (33.3%) re-
quired ICU admission and mechanical ventilation whilst
none of the other cases (with influenza A non-H1N1 or
Influenza B), p-value: 0.001. The mean duration of
Table 1 Baseline characteristics of patients with Influenza subtype H1N1 compared to other than H1N1 during the outbreak of 2017
Characteristic H1N1 (N = 57) Other than H1N1 (N = 31) p-value
Mean Age ± SD 53.5 ± 17.3 61.3 ± 12.6 0.035
Mean CURB score ± SD 1.9 ± 0.98 1.5 ± 0.99 0.091
Median Duration Of Illness (Range) 5 (2–10) 4 (2–7) 0.636
Gender 0.467
Male 23 15
Female 34 16
Pregnant 6 0 0.001
Smoking status 1.000
Current Smoker 7 4
Ex-Smoker 11 6
Non Smoker 36 20
Don’t know 3 1
Co-morbids
Diabetes 24 12 0.757
Hypertension 25 18 0.203
COPD 8 4
Cardiac Problems 13 3
Obesity 5 1
CVA 2 0
Malignancy 2 1
Immunosuppression 7 2
Abbreviations: COPD Chronic Obstructive Pulmonary disease; CVA Cerebrovascular Accident
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intubation was 3.06 days (SD: 4.97) among 19 patients,
who required mechanical ventilation. This was signifi-
cantly different when compared to patients who had in-
fluenza other than H1N1 as none of patients in that
group required mechanical ventilation. The mortality
among mechanically ventilated patient were 47.3% (n =
9/19). Twenty nine (33%) patients required non-invasive
ventilation (NIV). Twenty of 29 patients who required
NIV had H1N1 pneumonia. Five patients who required
NIV died and the association was not statistically signifi-
cant (p = 0.7); 4 of these patients had H1N1 pneumonia.
The hospital course was complicated by nosocomial
pneumonia in 8 (14%) of those with H1N1 influenza
compared to none in the other group (p-value: 0.046)
(Table 2). Patients were diagnosed to have superimposed
infection based on culture and sensitivity results of spu-
tum or bronchoscopy specimens obtained during course
of hospital stay. Acinetobacter species was isolated in 5
patients and Pseudomonas aeruginosa was isolated in 3
patients. Aspergillus species were identified from sputum
specimens of 8 patients, 6 at the time of admission and
2 during the course of hospital stay. Aspergillus flavus
was the predominant species in 6 out of 8 specimens. 4
patients in whom Aspergillus species had been isolated
had H1N1 pneumonia, one had Influenza A non- H1N1
and remaining had Influenza B pneumonia. None of
these patients required ICU admission and only one pa-
tient died.
Associated factors with H1N1 Influenza A compared
to other Influenza types were assessed using univariate
and multivariate analysis. In univariate analysis, presence
of ARDS and invasive ventilation were found to be
highly significant (p = value < 0.001). Other significant
risk factors included intensive care unit admission (p-
value: 0.001), septic shock (p-value: 0.015), respiratory
failure (p-value: 0.009) and increase in length of stay (p-
value: 0.001). However in the multivariable analysis, only
increase in length of stay was significantly associated
Table 2 Outcomes and Complications of patients with Influenza subtype H1N1 compared to other than H1N1 during the outbreak
of 2017
Variables H1N1 (N = 57) Other than H1N1 (N = 31) p-value
Type of admission
ICU 19 0 0.001
SCU 28 17 0.968
Ward 10 13 0.013
Management
Vasopressors 13 1 0.016
Non-invasive ventilation 20 9 0.564
Invasive Ventilation 19 0 < 0.001
Mean Duration Of Intubation ± SD 3.06 ± 4.97 0
Systemic Steroids 23 11 0.654
Antibiotics 56 29 0.282
Oseltamivir 57 28 0.041
Complications
Respiratory Failure 34 9 0.009
ARDS 18 0 < 0.001
Septic Shock 14 1 0.015
MODS 13 3 0.157
Nosocomial Infection 7 0 0.049
Acute Kidney Injury 24 6 0.032
NSTEMI 9 2 0.315
Outcome 0.359
Recovered 42 26
Dead 11 3
Unknown 4 2
Median Length Of Stay (Range) 6 (1–25) 3 (0–12) 0.001
Abbreviations: ICU Intensive care unit; SCU Special care unit; ARDS Acute Respiratory Distress Syndrome; MODS Multi-organ dysfunction Syndrome; NSTEMI Non- ST
elevation myocardial infarction
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with H1N1 Influenza infection (OR:1.47 CI: 1.2–1.8) and
increase in age was found to be protective for H1N1 in-
fection (OR:0.93 CI: 0.89–0.97) suggesting that H1N1
may be more predominantly affecting relatively younger
age groups after adjusting for confounding.
Subgroup analysis for factors associated with mortality
in H1N1 influenza was done using Fischer Exact test
and it was found that presence of ARDS, Septic shock
and multi-organ failure was highly significantly associ-
ated with death (p-value < 0.001) along with deranged
liver function tests (p-value 0.01) and presence of noso-
comial infection(p-value 0.027) (Table 3).
Discussion
The World Health Organization (WHO) declared Influenza
H1N1virus to have transitioned into post-pandemic period
but with the potential to cause outbreaks in 2010. WHO
Surveillance reports from December 2017 showed predom-
inant circulation of influenza A(H1N1)pdm09 virus with in-
fluenza A(H3N2) in Pakistan. Our study is the first from
the country to describe the clinical characteristics and out-
comes of patients affected with Influenza in that period. As
per CDC, Influenza season between 2017 and 2018 was of
high severity with multiple people visiting emergencies as
well outpatient clinics with Influenza like illness and deaths
due to pneumonia and influenza were reported to be ap-
proximately 10% nationally across the United States with
predominant circulating strain being Influenza A(H3N2)
[15]. As opposed to this, in Europe, the majority of cases
were due to influenza virus type B infection with excess
mortality from all causes as per European Centre for
Disease Prevention. However, from South Asia including,
Afghanistan and India, the predominant strain was H1N1
[16]. In a single center study from India, the mortality was
29% but it did not include cases from the 2017 outbreak. In
our study, overall mortality from Influenza was 15.9% and
mortality from H1N1 subtype was 19%. Study from
Pakistan sentinel sites reported 11% mortality from H1N1
in 2009 [13] and 16% in another single center study [12].
Mean age in our cohort was 55 years as opposed to 36 years
during the 2009 Influenza outbreak in Pakistan [13].
However gender distribution also reflected similar predilec-
tion for females [12]. Among the risk factors, we did not
find significant association with smoking or obesity as
reported from other studies [17, 18] and majority of our
patients were non-smokers as opposed to another study
from Pakistan [13]. Eighteen percent required ICU admis-
sion as compared to 27% in another study done during the
2009 pandemic [12].
Secondary bacterial pneumonia is a well-recognized
complication of influenza and most commonly implicated
organisms include Staphylococcus aureus Streptococcus
pneumonia and Klebsiella sp. [19]. In our study we found
Aspergillus species in 6 out of 23 sputum specimens sent
at admission with 3 having concomitant Staphylococcus
aureus. S. aureus has been reported to cause superim-
posed infection in patients with H1N1 influenza [20, 21].
However, Aspergillus species have recently been reported
to complicate severe influenza infections [22]. Influenza
associated Aspergillosis (IAA) has been reported to occur
in immunocompetent patients with Influenza and a large
multicenter study from Netherlands reported 16% IAA in
their cohort. They also concluded that approximately all
cases that have been reported so far are associated with in-
fluenza A H1N1 infection [23]. However, the limitation of
our study is that we could not differentiate colonization
with Aspergillus from Influenza associated Aspergillosis.
Moreover our study has limited generalizability as it’s a
single center study. Findings from this study have implica-
tions for management in developing countries where the
burden of multi-drug resistant healthcare associated infec-
tions and invasive fungal infections is high [24, 25] and
may adversely affect outcomes in Influenza A H1N1 pneu-
monia since mortality is greater in patient who developed
nosocomial infections.
Conclusion
Influenza A H1N1 is associated with greater length of
stay compared with infection due to other types of Influ-
enza and mortality in H1N1 Pneumonia was found to be
associated with presence of nosocomial infection among
several other factors which may have implications given
higher rates in a low-middle income country.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s41479-020-00070-7.
Additional file 1: Supplementary Table 1. Laboratory Data for H1N1
pneumonia patients compared to Influenza other than H1N1.
Abbreviations: WBC: White blood cell count; CRP: C-reactive protein; SGPT:
Serum glutamic pyruvic transaminase.
Abbreviations
WHO: World Health Organization; CDC: Centers for Disease Control and
Prevention; ARDS: Acute respiratory distress syndrome; ERC: Ethical Review
Committee; ILI: Influenza-like illness; RT-PCR: Real-time reverse transcriptase
Table 3 Subgroup analysis for mortality in H1N1 pneumonia
Variables Died (n = 11) Recovered (n = 42) p-value
Invasive ventilation 9 9 < 0.001
Respiratory failure 10 20 0.001
ARDS 10 7 < 0.001
Septic Shock 10 4 < 0.001
MODS 9 2 < 0.001
Nosocomial Infection 4 3 0.027
Transaminitis 7 6 0.010
Abbreviations: ARDS Acute Respiratory Distress Syndrome; MODS Multi-organ
dysfunction Syndrome
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polymerase chain reaction; CAP: Community acquired pneumonia;
COPD: Chronic Obstructive Pulmonary disease; SGPT: Serum glutamic pyruvic
transaminase; SGOT: Serum glutamic-oxaloacetic transaminase; ICU: Intensive
care unit; NIV: Non-invasive ventilation; IAA: Influenza associated aspergillosis
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